NDC 51525-6831

TriLyte with Flavor Packs

Polyethylene Glyocol 3350, Sodium Chloride, Sodium Bicarbonate And Potassium Chloride

TriLyte with Flavor Packs is a Nasogastric; Oral Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Wallace Pharmaceuticals Inc.. The primary component is Polyethylene Glycol 3350; Sodium Chloride; Sodium Bicarbonate; Potassium Chloride.

• Product ID: 51525-6831_0d80cbb9-e846-443c-bbfe-64a565f61663
• NDC: 51525-6831
• Product Type: Human Prescription Drug
• Proprietary Name: TriLyte with Flavor Packs
• Generic Name: Polyethylene Glyocol 3350, Sodium Chloride, Sodium Bicarbonate And Potassium Chloride
• Dosage Form: Powder, For Solution
• Route of Administration: NASOGASTRIC; ORAL
• Marketing Start Date: 2016-10-01
• Marketing Category: ANDA / ANDA
• Application Number: ANDA076491
• Labeler Name: Wallace Pharmaceuticals Inc.
• Substance Name: POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE
• Active Ingredient Strength: 420 g/4L; g/4L; g/4L; g/4L
• Pharm Classes: Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 51525-6831-4

4 L in 1 BOTTLE (51525-6831-4)

• Marketing Start Date: 2016-10-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51525-6831-4 [51525683104]

TriLyte with Flavor Packs POWDER, FOR SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA076491
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2016-10-01

Drug Details

Active Ingredients

Ingredient	Strength
POLYETHYLENE GLYCOL 3350	420 g/4L

OpenFDA Data

• SPL SET ID: 486598b1-0358-11e3-8ffd-0800200c9a66
• Manufacturer:
  • Wallace Pharmaceuticals Inc.
• UNII:
  • 8MDF5V39QO
  • G2M7P15E5P
  • 451W47IQ8X
  • 660YQ98I10
• RxNorm Concept Unique ID - RxCUI:
  • 904158
  • 801054

Pharmacological Class

• Osmotic Activity [MoA]
• Osmotic Laxative [EPC]
• Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]
• Potassium Compounds [CS]
• Potassium Salt [EPC]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]

Medicade Reported Pricing

51525683104 TRILYTE WITH FLAVOR PACKETS

Pricing Unit: ML | Drug Type: